Expression of multidrug resistant gene (mdr-1/P-glycoprotein) in a megakaryoblastic cell line, CMK, and its enhancement during megakaryocytic differentiation

Leuk Lymphoma. 1995 Aug;18(5-6):515-20. doi: 10.3109/10428199509059654.

Abstract

Multidrug resistance is a severe clinical problem in the chemotherapy of malignant disease. Acute megakaryoblastic leukemia (AMKL) is a rare form of childhood leukemia, and is often resistant to many anti-cancer chemotherapeutic drugs. Here we report the expression of the mdr-1/P-glycoprotein in a cell line, CMK, established from a patient with AMKL. Expression of mdr-1 mRNA in CMK11-5 cells, a well differentiated subline, was higher than in CMK6 cells, a poorly differentiated subline. The level of P-glycoprotein was also higher in CMK11-5 cells. The cytokines interferon-gamma (IFN-gamma), GM-CSF and IL-3, which were shown to induce megakaryocytic differentiation of CMK cells, enhanced the expression of the mdr-1 mRNA and levels of P-glycoprotein. These results imply that differentiated megakaryocytic cells may have higher levels of the P-glycoprotein expression, suggesting a possible normal physiological function of P-glycoprotein in mature megakaryocytes.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / genetics*
  • Cell Differentiation
  • Cytokines / pharmacology
  • DNA, Neoplasm / genetics
  • Drug Resistance, Multiple*
  • Gene Expression Regulation, Neoplastic / drug effects
  • Genes
  • Humans
  • Immunoenzyme Techniques
  • Leukemia, Megakaryoblastic, Acute / genetics*
  • Megakaryocytes / metabolism*
  • RNA, Messenger / genetics
  • RNA, Neoplasm / genetics

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Cytokines
  • DNA, Neoplasm
  • RNA, Messenger
  • RNA, Neoplasm